Aacr 2023 Highlights On Advances In The Treatment Of Hepatocellular Carcinoma With Pierce Chow

AACR 2023 highlights on advances in the treatment of hepatocellular carcinoma with Pierce Chow

European Society for Medical Oncology (ESMO)

AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber

European Society for Medical Oncology (ESMO)

AACR 2023 highlights on advances in the treatment of biliary tract cancer with Robin Katie Kelley

European Society for Medical Oncology (ESMO)

AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John Heymach

European Society for Medical Oncology (ESMO)

Takeaways in hepatocellular carcinoma at ASCO GI 2023

IMbrave050: adjuvant atezolizumab with bevacizumab in high-risk HCC

Choosing the best treatment regimen in advanced hepatocellular carcinoma

Atezo plus bev demonstrates efficacy in preventing recurrence in patients with high-risk HCC

Advancements in immunotherapy for hepatocellular carcinoma

Opening and Updates on Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group

National Cancer Centre Singapore

Recent immunotherapy advances in HCC management

Assessing treatment options for hepatocellular carcinoma

Highlights from ESMO Asia 2022 in HCC

Screening for Hepatocellular Carcinoma: Recent Advances by Prof. Amit Singal, MD

INEDSYS Library

SIRT Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (SIRveNIB Study)

Hepatocellular Carcinoma | Advanced Cancer treatment | Immunotherapy | Targeted therapy

Dr Animesh Saha

AACR 2023 Recap with Dr. Christopher Klebanoff

Cancer Research Institute

Highlights on belzutifan in previously treated advanced clear cell RCC: The LITESPARK-005 study

European Society for Medical Oncology (ESMO)

Sequencing treatment options for HCC

ESMO 2023 highlights: advances in EGFR+ lung cancer second-line therapy